Table 1.
Overview of background characteristics, disease burden, ambulatory care costs and Quality-of-life separately for all ILI patients and the ones clinically diagnosed as flu, according to type of health care used.
Table 2.
Estimated direct medical cost and quality-of-life associated with ILI and clinically diagnosed flu patients in Belgium, as a function of significant predictor variables (gender, underlying condition ‘cond’, age and/or vaccination status (‘vac’ = vaccinated just before or during the last flu season)).
Figure 1.
Costs for ambulatory ILI patients.
Estimated average direct medical cost (€, using lowest unit cost for medication) as a function of having an underlying illness and age, separately for ambulatory ILI respondents categorized as ‘likely flu’ or ‘unlikely flu’.
Figure 2.
Quality-Adjusted Life-Years lost for ambulatory ILI patients.
Estimated average Quality-Adjusted Life-Years lost as a function of having an underlying illness and age, separately for ambulatory ILI respondents categorized as ‘likely flu’ or ‘unlikely flu’.
Figure 3.
Medication use of ILI patients.
Number of respondents using different types of medication, separately for medication bought in the pharmacy and medication that respondents had in storage at home. Each respondent could specify several types of medication bought or at home. ‘Don’t know’ refers to medication taken without being sure about which type.